diff --git a/src/contents/description.tsx b/src/contents/description.tsx
index 061cd536ad1789f57980242b6c169a58237c9cea..f49037c4a2c270b1801482e6c08d528015b6fb53 100644
--- a/src/contents/description.tsx
+++ b/src/contents/description.tsx
@@ -110,13 +110,13 @@ export function Description() {
                     </div>
                 </Subesction>
                 <Subesction title="Treatment" id="Cystic Fibrosis6">
-                    <img src="https://static.igem.wiki/teams/5247/placeholders/placehilderperson.jpeg"/> 
+                    <p>Cystic fibrosis therapy means inevitably a complex and customized treatment plan for each patient. It consists of a range of components. These include medication such as CFTR modulators and antibiotics as well as inhalation therapy and mucolytics, physiotherapy, nutritional therapy and sports therapy. It is therefore essential that CF patients receive treatment at a specialist centre [1].</p>
                     <Collapsible id="drugs-collapsible" title="Different types of drugs" >
                     <TabButtonRow data={medibuttonrowdata} opentype="symptabs" closing=""/>
                     <ButtonRowTabs data={medibuttonrowdata} cla="symptabs"/>
                     </Collapsible>
-                    <H2 text="The future of CF treatment with gene therapy"></H2>
-                    <p> While mentioned medications have improved the quality of life for numerous CF patients, they only manage symptoms rather than cure the disease. Moreover, most of them are expensive and not world-wide accessible. Our research is focused on the development of a gene therapy that targets the underlying cause of CF by correcting the defective CFTR gene. <PreCyse/> aims to halt disease progression and reduce the treatment burden for patients."</p>
+                    <H2 text="CF treatment with gene therapy"></H2>
+                    <p>While mentioned medications have improved the quality of life for numerous CF patients, they only manage symptoms rather than cure the disease. Moreover, most of them are expensive and not world-wide accessible. Our research is focused on the development of a gene therapy that targets the underlying cause of CF by correcting the defective CFTR gene. <PreCyse/> aims to halt disease progression and reduce the treatment burden for patients.</p>
                     <img src="https://static.igem.wiki/teams/5247/charts-maps/cfper10-000.png"/> 
                 </Subesction>
             </Section>